Oddo BHF - DEME GROUP NV (DEME) DEME Group : Strong Q3 sales, 2024 sales guidance upped, EBITDA guidance unchanged

Report

Oddo BHF

Thijs Berkelder

DEME Group : Strong Q3 sales, 2024 sales guidance upped, EBITDA guidance unchanged

>Very strong Q3 sales: beat of 16% and yoy growth of 40% - In its Q3 sales and order book update, DEME reported sales of €1.16bn, a beat of 16% versus our estimate (no css available). That €1.16bn in sales also means YoY growth of 39.9%, a clear acceleration versus growth in the first 6 months of 2024 which amounted to 29.9%. Offshore Energy did extremely well with YoY growth in Q3 of 86% (H1 2024 YoY growth was 38%) driven by higher capacity (fleet extensions) and hi...

14/11/2024 1 EN

Underlying

DEME GROUP NV

See profile

BE0974413453 Euronext Brussels Belgium

Provider

Oddo BHF

Oddo Securities provides securities brokerage and research services. The company offers equity, economic, and derivatives research and credit analysis services. It focuses on insurance, automotive, building materials, pharmaceuticals, telecommunications, information technology, and agri-food industries.

See profile

Analysts

Thijs Berkelder

Other Reports on these Companies

Oddo BHF

ODDO BHF Small & MIDCAP MORNING NEWS - Date1

We initiate coverage of Heijmans, a contractor focused on the Dutch market, with an Outperform rating and a TP of € 36.5 (DCF based). The Dutch residential market is finally recovering, and we believe Heijmans is well-positioned to benefit due to its land bank and property development arm, driving up revenues while EBITDA margins are expected to exceed 8.5% in the Living unit. Heijmans is also benefitting from strong demand from the infrastructure and energy markets, allowing for soli...

7h / 41m 7h / 41m 1 FR

Oddo BHF

ODDO BHF Small & MIDCAP MORNING NEWS - 11/14/2024

7h / 47m 7h / 47m 1 EN

ING Financial Markets

Benelux Morning Notes

Agfa-Geveart: Material miss on Healthcare activities. ASML: Long-term guidance confirmed. CVC Capital Partners: Comfortably on track. DEME Group: Raises outlook, lowers capex guidance. Proximus: Pressure on CEO from another possible coalition party. SBM Offshore: Again delivering

10h / 19m 10h / 19m 1 EN

Accelleron : Straight and smooth sailing with a compounder profile

Swiss-based Accelleron was formed from the spin-off of ABB’s highly profitable turbocharger division in 2022. We view the share as a promising investment on 1/ market leadership in an attractive niche, 2/ about ~40% ROCE, 3/ conversion of ~80% of EBITDA into cash, leading to fast deleveraging, and a solid base for shareholder remuneration (75% pay out), and 4/ strong long-term visibility linked to a ~75% service share, the bulk of which is recurring. Despite an already strong sto...

1h / 30m 1h / 30m 1 EN

Oliver Metzger ... (+2)

Oliver Metzger
Stephan Wulf

Dermapharm Holding SE : All divisions contribute to better-than-expected 9M figures

>A strong set of 9M figures beats expectations - 9M sales of € 890m (+3%) came in 1% above our (€ 886m) and 2% above the consensus compiled by the company of € 871m. Adjusted EBITDA of € 240m (-1%) is 5% above our estimates of € 229m and 8% above consensus of € 223m. The slightly lower profitability vs 9M 2023 (adjusted EBITDA margin of 27% vs 28%) still reflects the absence of sales from the extremely attractive contract with BioNTech, which still supported Q1 2023....

7h / 39m 7h / 39m 1 EN

Thijs Berkelder ... (+2)

Thijs Berkelder
Usama Tariq

ODDO BHF Small & MIDCAP MORNING NEWS - Date1

7h / 41m 7h / 41m 1 FR

Sign-up for free to access full reports immediately

Email Address*

Choose Password* ( 6 or more characters )

Due to regulatory restrictions regarding the distribution of financial research, this report is restricted to a specific region or investor type. Get access to exclusive reports by answering the questions below.

Select your country*

Get financial insights straight to your inbox

By clicking "register" you accept the Terms and Conditions & Privacy Policy

Already on ResearchPool?

Almost there...

Are you a professional investor?

Select your country

REGISTER

Create a free ResearchPool account to access full reports, get a personalised dashboard and follow providers or companies

In order to access this report please create an account.

LOGIN

DEME Group : Strong Q3 sales, 2024 sales guidance upped, EBITDA guidance unchanged

ODDO BHF Small & MIDCAP MORNING NEWS - Date1

ODDO BHF Small & MIDCAP MORNING NEWS - 11/14/2024

Benelux Morning Notes

Accelleron : Straight and smooth sailing with a compounder profile

Dermapharm Holding SE : All divisions contribute to better-than-expected 9M figures

ODDO BHF Small & MIDCAP MORNING NEWS - Date1

Create a free ResearchPool account to access full reports, get a personalised dashboard and follow providers or companies

Sign-up for free to access full reports immediately

ResearchPool Subscriptions

Get the most out of your insights

Why subscribe?

How to subscribe

ResearchPool Subscriptions

This report is only available to subscribers

Why subscribe?

How to subscribe